The relationship between radiation dose and bevacizumab-related imaging abnormality in patients with brain tumors: A voxel-wise normal tissue complication probability (NTCP) analysis.
Mia SalansJordan HouriRoshan KarunamuniAustin HopperRachel DelfantiTyler M SeibertNaeim BahramiYasamin SharifzadehCarrie McDonaldAnders DaleVitali MoiseenkoNikdokht FaridJona A Hattangadi-GluthPublished in: PloS one (2023)
BRIA is likely a radiation dose-dependent phenomenon in patients with brain tumors receiving bevacizumab and radiotherapy. The combination of radiation effects and tumor microenvironmental factors in potentiating BRIA in this population should be further investigated.